PATTERNOX
Innovative imaging to detect skin and lesion deformities for cosmetics and skin cancer
Company Overview
Snapshot
Founded in September 2019 by Ofir Aharon, PATTERNOX operates with 1–10 employees. The company has secured $500,000 in total capital across one funding round. In February 2025, PATTERNOX was recognized with the First Prize by Migdal and Shark Tank, highlighting its innovative approach to early skin cancer detection.
Business overview
PATTERNOX LTD develops an innovative imaging method called Lateral Movements of Backscattered-light (LMB) to detect tissue distortions beneath the skin surface. This technology identifies early indicators of skin deformities that could progress into skin cancer or cosmetic concerns, without relying on traditional color changes. The company's core product, PatScope, serves the Health Tech & Life Sciences sector, focusing on medical devices, digital healthcare, and diagnostics, utilizing artificial intelligence and machine learning to provide non-invasive diagnostic solutions for healthcare providers.
Strategic signal
In February 2025, PATTERNOX received the First Prize by Migdal and Shark Tank. This recognition validates the company's innovative approach to early skin cancer detection and signals strong market potential and investor interest in its non-invasive diagnostic technology. For investors, this indicates a significant milestone in commercial validation and potential for accelerated growth in the digital healthcare and medical technologies sector.
Log in to access full profile ›Company Intelligence Q&A
- What is PATTERNOX's core technology?
- PATTERNOX has developed an innovative imaging method called Lateral Movements of Backscattered-light (LMB). This technology extracts tissue distortions below the skin surface, enabling early detection of skin and lesion deformities for cosmetic and skin cancer applications.
- When was PATTERNOX founded?
- PATTERNOX was founded in September 2019 by Ofir Aharon.
- What recognition did PATTERNOX receive in February 2025?
- In February 2025, PATTERNOX was awarded the First Prize by Migdal and Shark Tank for its innovative lesion distortions scanner device.
- What is the primary application of PATTERNOX's technology?
- PATTERNOX's technology is primarily used for the early detection of skin cancer and cosmetic concerns by identifying tissue distortions before they manifest as visible color changes.
- What is the name of PATTERNOX's primary product?
- PATTERNOX's primary product is called PatScope, a device designed for the early examination of skin cancer.